Coherus Biosciences(CH:8C5)
CH:8C5
Coherus Biosciences earnings date
Coherus Biosciences (8C5) Q2 2026 Earnings Report
0 Followers
CH:8C5 Q2 2026 EPS Results
- Actual EPS
- -CHF 0.18
- Consensus EPS
- -CHF 0.21
- Beat/Miss
- Beat by +CHF 0.03
- One Year Ago EPS
- -CHF 0.33
CH:8C5 Q2 2026 Revenue Results
- Actual Revenue
- CHF 12.03M
- Expected Revenue
- CHF 12.11M
- Beat/Miss
- Missed by -CHF 83.23K
- YoY Revenue Growth
- +39.53%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- During Market Hours
- Conference Call
- Wednesday, August 5, 2026
CH:8C5 Upcoming Earnings
Coherus Biosciences's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:8C5 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:8C5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -0.16- | -0.33 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.18-0.21 | -0.26 | 19.35% (+0.05) | |
| Aug 05, 2026 | 2026 (Q2) | -0.21-0.18 | -0.33 | 43.59% (+0.14) | |
| May 11, 2026 | 2026 (Q1) | -0.18-0.23 | -0.34 | 34.15% (+0.12) | |
| Mar 09, 2026 | 2025 (Q4) | -0.30-0.33 | -0.37 | 11.36% (+0.04) | |
| Nov 06, 2025 | 2025 (Q3) | -0.30-0.26 | -0.08 | -244.44% (-0.18) | |
| Aug 07, 2025 | 2025 (Q2) | -0.18-0.33 | -0.09 | -254.55% (-0.24) | |
| May 12, 2025 | 2025 (Q1) | -0.25-0.34 | 0.7 | -149.40% (-1.04) | |
| Mar 10, 2025 | 2024 (Q4) | -0.26-0.37 | -0.6 | 38.03% (+0.23) | |
| Nov 06, 2024 | 2024 (Q3) | -0.14-0.08 | -0.34 | 78.05% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

